Assize Index

糖與代糖

甜菊糖(Reb A)

GI(Glucose = 100)

主要來源 · 0 GI

High-intensity sweeteners — no available carbohydrate for classical GI (2020)

Energy(kcal/100g)

主要來源 · 0 kcal/100g

High-intensity sweeteners — no available carbohydrate for classical GI (2020)

Carbs(g/100g)

主要來源 · 0 g/100g

High-intensity sweeteners — no available carbohydrate for classical GI (2020)

Sugars(g/100g)

主要來源 · 0 g/100g

High-intensity sweeteners — no available carbohydrate for classical GI (2020)

功能性益處

還沒有附出處的礦物質或其他功能註記。

已引述的礦物質可在 日常最適合的甜味劑 上最多加 +2 分,見 Methods。

風險與副作用

  • 高強度甜味劑

    note

    Use-level and blends matter. Packet fillers are different products. Regulatory class note — not scored.

    FDA — High-intensity sweeteners permitted for use in food (2023)

  • WHO 不建議用於體重控制

    caution

    WHO 2023, conditional (low certainty): not for weight control or lowering disease risk — no long-term body-fat benefit. Not a safety ruling. Scored: the energy points it earns over sucrose are taken back on Everyday Health, Weight goals and Easy on the liver; not on Diabetic-friendly (WHO excludes people with diabetes). Named in WHO's examples (stevia and stevia derivatives).

    WHO — Use of non-sugar sweeteners: WHO guideline (2023)

這不是醫療建議。若該項目會依公開公式扣分,細節列在「分數怎麼算」;分數不代表臨床嚴重程度。

註記

還沒有額外的背景註記。

註記說明公開軸或風險標籤本身看不出來的事,不是醫療建議。

空白表示目前找不到方法清楚、可引用的資料。表格第一名只代表依公開規則計算後居首,不是醫療認證。